Clinical trial
Evaluation of Drug Interaction Between HS-10234 and Emtriccitabine
NCT04477096
Study timeline
Study start (actual)2020-08-03Date precision: day
Registry last updated2020-10-01
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Healthy Subjectsunresolved
Interventions
HS-10234DRUG
EmtricitabineDRUG · verified · RxNorm: emtricitabine
Sponsors & collaborators
Jiangsu Hansoh Pharmaceutical Co., Ltd.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04477096 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.